Unreviewed,
UniProtKB/TrEMBL Q53GF1 (Q53GF1_HUMAN)
Last modified
January 19, 2010.
Version 28.
History...
Clusters with 100%,
90%,
50% identity |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin · Protein attributes · Ontologies · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information
Names and origin
| Protein names | Submitted name: Matrix metalloproteinase 7 preproprotein variant EMBL BAD96700.1 |
| Organism | Homo sapiens (Human) EMBL BAD96700.1 |
| Taxonomic identifier | 9606 [NCBI] |
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 267 AA. |
| Sequence status | Fragment. |
| Protein existence | Evidence at transcript level. |
Ontologies
| Keywords | |
|---|---|
| Ligand | Metal-binding Spearmint SPM002477 Zinc Spearmint SPM002477 |
| Molecular function | Hydrolase Metalloprotease Spearmint SPM002477 Protease |
| Gene Ontology (GO) | |
| Biological process | proteolysis Inferred from electronic annotation. Source: InterPro regulation of cell proliferationInferred from electronic annotation. Source: Compara |
| Cellular component | proteinaceous extracellular matrix Inferred from electronic annotation. Source: InterPro |
| Molecular function | metalloendopeptidase activity Inferred from electronic annotation. Source: InterPro zinc ion bindingInferred from electronic annotation. Source: UniProtKB-KW |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||
Experimental info | ||||||||
|---|---|---|---|---|---|---|---|---|
| Non-terminal residue | 1 | 1 | EMBL BAD96700.1 | |||||
Sequences
| ||||||||||||||||||
References
| [1] | "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides." Maruyama K., Sugano S. Gene 138:171-174(1994) [PubMed: 8125298] [Abstract] Cited for: NUCLEOTIDE SEQUENCE. Tissue: Human small intestine EMBL BAD96700.1. |
| [2] | "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library." Suzuki Y., Yoshitomo K., Maruyama K., Suyama A., Sugano S. Gene 200:149-156(1997) [PubMed: 9373149] [Abstract] Cited for: NUCLEOTIDE SEQUENCE. Tissue: Human small intestine EMBL BAD96700.1. |
| [3] | Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S. Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE. Tissue: Human small intestine EMBL BAD96700.1. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AK222980 mRNA. Translation: BAD96700.1. |
| IPI | IPI00013400. |
| UniGene | Hs.2256 |
3D structure databases | |
| SMR | Q53GF1. Positions 32-264, 96-266. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | Q53GF1. |
Genome annotation databases | |
| Ensembl | ENST00000260227; ENSP00000260227; ENSG00000137673; Homo sapiens. [Genome view] |
Organism-specific databases | |
| HGNC | HGNC:7174. MMP7. |
Phylogenomic databases | |
| HOVERGEN | Q53GF1. |
Gene expression databases | |
| ArrayExpress | Q53GF1. |
| Bgee | Q53GF1. |
Family and domain databases | |
| InterPro | IPR001818. Pept_M10A_M12B. IPR006026. Peptidase_M. IPR002477. Peptidoglycan-bd-like. [Graphical view] |
| Pfam | PF00413. Peptidase_M10. 1 hit. PF01471. PG_binding_1. 1 hit. [Graphical view] |
| PRINTS | PR00138. MATRIXIN. |
| SMART | SM00235. ZnMc. 1 hit. [Graphical view] |
| PROSITE | PS00546. CYSTEINE_SWITCH. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Entry information
| Entry name | Q53GF1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q53GF1 | ||||||||
| Entry history |
| ||||||||
| Entry status | Unreviewed (UniProtKB/TrEMBL) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||

Clusters with


